))
ART Doesn’t Increase Hormone Receptor-Positive Breast Cancer Recurrence Risk
Manage episode 388173608 series 3525104
Contenu fourni par Breastcancer.org. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Breastcancer.org ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
At the 2023 San Antonio Breast Cancer Symposium, Dr. Hatem Azim presented a new analysis of information from the POSITIVE trial, which found that younger women diagnosed with early-stage, hormone receptor-positive breast cancer could safely pause hormonal therapy to try to become pregnant. His new analysis looked at whether the women could use fertility preservation and assisted reproductive technologies (ART) without increasing the risk of the cancer coming back (recurrence).
Listen to the podcast to hear Dr. Azim discuss:
- the types of fertility preservation and ART used
- which techniques were the most successful
- the results of his analysis
300 episodes
Partager
